Ocugen Inc. (OCGN): What is the Risk Factor?

Ocugen Inc. (NASDAQ:OCGN) saw a downside of -2.79% to close Friday at $6.98 after subtracting -$0.2 on the day. The 5-day average trading volume is 10,428,340 shares of the company’s common stock. It has gained $7.95 in the past week and touched a new high 1 time within the past 5 days. An average of 13,073,805 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 12,254,468.

OCGN’s 1-month performance is -7.18% or -$0.54 on its low of $6.75 reached on 10/01/21. The company’s shares have touched a 52-week low of $0.25 and high of $18.77, with the stock’s rally to the 52-week high happening on 02/08/21. YTD, OCGN has achieved 281.42% or $5.15 and has reached a new high 4 times. However, the current price is down -62.81%% from the 52-week high price.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


Insider Transactions

On Sep 15, 19 days have gone by since the last insider trading activity for Ocugen Inc. (OCGN). Musunuri Shankar (Chief Executive Officer) most recently sold 125,000 shares at $7.52 per share on Sep 15. This transaction cost the insider $940,000. Chief Financial Officer, Subramanian Sanjay, sold 30,000 shares at a price of $7.22 on Aug 16. Then, on Jul 30, Director Kompella Uday sold 10,000 shares at a price of $6.81 per share. This transaction amounted to $68,072.

Valuation Metrics

Ocugen Inc. (OCGN) has a trailing price-to-earnings (P/E) ratio of 33.83 for the broader industry and 32.48 for the sector, meaning that investors are optimistic about the stock’s future prospects.OCGN stock has a beta of 4.47. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 33485.00 while the price-to-book (PB) in the most recent quarter is 11.63.

Ocugen Inc.’s quick ratio for the period ended June 29 was 25.10, with the current ratio over the same period at 25.10 meaning that OCGN stock is able to fulfill its debt obligations. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.01, while the total debt to equity was 0.01. The firm’s gross profit as reported stood at $21.33 million against revenue of $43000.0.

Earnings Surprise

For the quarterly period ending June 29 this year, Analysts expected OCGN to announce -$0.03 per share in earnings in its latest quarter, but it posted -$0.13, representing a -333.30% surprise. EBITDA for the quarter stood at more than -$25.56 million. OCGN stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 7.84 million, with total debt at $3.17 million. Shareholders hold equity totaling $198.76 million

Technical Picture

Let’s look briefly at Ocugen Inc. (OCGN) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 01 October was 41.17% to suggest the stock is trending Neutral, with historical volatility in this time period at 55.56%.

The stock’s 5-day moving average is $7.16, reflecting a -7.30% or -$0.55 change from its current price. OCGN is currently trading -8.76% above its 20-day SMA, -29.49% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by -1.41% and +2,249.38% respectively.

Stochastic %K and %D was 13.14% and 13.27% and the average true range (ATR) pointed at 0.46. The RSI (14) points at 44.02%, while the 14-day stochastic is at 16.20% with the period’s ATR at 0.48. The stock’s 9-day MACD Oscillator is pointing at -0.34 and -0.43 on the 14-day charts.

Analyst Ratings

In the most recent analyst report for Ocugen Inc. (NASDAQ: OCGN), Noble Capital Markets launched coverage with an Outperform rating. Analysts offering their rating for OCGN stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate OCGN as a “sell,”, while 2 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 2 have offered a “buy” rating.

What is OCGN’s price target for the next 12 months?

Analysts have a consensus price target ranging from a low of $4.00 and a high of $15.00, with their median price target at $8.00. Looking at these predictions, the average price target given by analysts is for Ocugen Inc. (OCGN) stock is $8.75.


Please enter your comment!
Please enter your name here


Hot Topics

Related Videos

Related Videos

Related Articles



Download Free eBook For



100% free. stop anytime no spam